Gracell Biotechnologies (GRCL) Price/Sales Ratio

Price: $10.25
Market Cap: $989.87M
Avg Volume: 1.46M
Country: CN
Industry: Biotechnology
Sector: Healthcare
Beta: -0.345
52W Range: $1.4-10.435
Website: Gracell Biotechnologies

What is Gracell Biotechnologies's Price/Sales Ratio?

  • Gracell Biotechnologies's trailing twelve month (TTM) Price/Sales ratio is 0.00.
  • Gracell Biotechnologies's annual Price/Sales ratio as of today is 0.00.
  • Gracell Biotechnologies's quarterly Price/Sales ratio is 0.00.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess Gracell Biotechnologies's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -2.81
    • Quarterly: -6.52
    • TTM: -29.10
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 1.24
    • Quarterly: 1.09
    • TTM: 3.85
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -3.53
    • Quarterly: 0.00
    • TTM: 0.00
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
    • Annual: 0.14
    • Quarterly: 0.10
    • TTM: -0.29

These metrics provide insights into Gracell Biotechnologies's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Sales Ratio

0.00

Quarterly Price/Sales Ratio

0.00

TTM Price/Sales Ratio

0.00

Gracell Biotechnologies Historical Price/Sales Ratio
8000.008000.006000.006000.004000.004000.002000.002000.000.000.00Price/Sales Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical P/E Ratio
0.000.00-10.00-10.00-20.00-20.00-30.00-30.00-40.00-40.00-50.00-50.00-60.00-60.00P/E Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical P/B Ratio
1600.001600.001200.001200.00800.00800.00400.00400.000.000.00P/B Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical P/C Ratio
0.000.00-10.00-10.00-20.00-20.00-30.00-30.00-40.00-40.00-50.00-50.00-60.00-60.00P/C Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical PEG Ratio
1.421.420.870.870.330.33-0.22-0.22PEG Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Gracell Biotechnologies Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year Price/Sales Ratio P/E Ratio P/B Ratio P/C Ratio PEG Ratio
2022 0.00 -2.81 1.24 -3.53 0.14
2021 6894.82 -5.42 1.38 -8.29 -0.04
2020 0.00 -54.38 13.08 -54.10 0.99
2019 0.00 -26.15 13.53 -25.52 -0.22
2018 0.00 -56.14 1432.24 -55.18 0.00

Related Metrics

Explore detailed financial metrics and analysis for GRCL.